newsfilter
← Latest News
GlobeNewswire·

BeyondSpring Files 2022 Annual Report on Form 20-F

NEW YORK, April 18, 2023 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the "Company" or "BeyondSpring") (NASDAQ:BYSI), a clinical-stage global biopharmaceutical company focused on using its novel technology platform for drug